Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Enrolling By Invitation NCT05618600

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

Conditions: COVID-19

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 800

Sponsor: Scripps Translational Science Institute

Location: United States

Summary

A prospective monitoring study for those individuals treated with Paxlovid

Eligibility Criteria

Inclusion Criteria:Age > 18Covid positiveQualified for Paxlovid prescription (treatment decision already made prior to enrollment)Exclusion Criteria:Non-english speakingResides outside of the United States

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05618600). StuddyBuddy aggregates publicly available trial information.